Arvinas, Inc. (ARVN)
12.97
-0.47
(-3.50%)
USD |
NASDAQ |
Feb 11, 10:45
Arvinas Market Cap : 832.99M for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 157.55B |
| Genprex, Inc. | 2.069M |
| Olema Pharmaceuticals, Inc. | 1.569B |
| ACADIA Pharmaceuticals, Inc. | 3.773B |
| Alnylam Pharmaceuticals, Inc. | 42.55B |
Market Cap Related Metrics
| PS Ratio | 3.021 |
| Price to Book Value | 1.476 |
| Price | 12.97 |
| Earnings Yield | -6.19% |